Corvus Pharmaceuticals, Inc. (CRVS) vs Verastem, Inc. (VSTM)
- Corvus Pharmaceuticals, Inc. CRVS 9.52 −3.35%
- Verastem, Inc. VSTM 8.65 −6.28%
Corvus Pharmaceuticals, Inc. and Verastem, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Verastem, Inc. are of similar size ($835.9M and $828.6M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −231.6%) and the lower return on invested capital (−352.5% vs 0.00%). Across the 14 metrics below, Corvus Pharmaceuticals, Inc. leads on 11 and Verastem, Inc. on 3.
Valuation
Profitability
| Metric | CRVS | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 86.35% | 65.16% |
| Operating margin | 0.00% | (182.57%) | 0.00% |
| Net margin | 0.00% | (231.59%) | 0.00% |
| Free cash flow margin | 0.00% | (185.31%) | 0.00% |
| Return on equity | (18.98%) | (471.16%) | (56.36%) |
| Return on assets | (17.64%) | (100.65%) | (48.04%) |
| Return on invested capital | (352.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack